Track topics on Twitter Track topics that are important to you
IMBio is a privately held Canadian biotechnology company focused on developing medical device products for use in the area of embolotherapy. Lead product, OCL 500 microspheres for the treatment of unresectable/inoperable hypervascularized tumours has received marketing clearance from the FDA in the U.S. Other products in development include rapidly-dissolving, drug-eluting and/or radio-labelled microspheres as well as biodegradable coils and stents for use in aneurysms that are not conducive to treatment with microspheres.
IMBio is a privately held Canadian biotechnology company focused on developing medical device products for use in the area of embolotherapy. Lead product, OCL 500 microspheres for the treatment of...
We have published hundreds of IMBiotechnologies Ltd news stories on BioPortfolio along with dozens of IMBiotechnologies Ltd Clinical Trials and PubMed Articles about IMBiotechnologies Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IMBiotechnologies Ltd Companies in our database. You can also find out about relevant IMBiotechnologies Ltd Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...